EKSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ekso Bionics Holdings Inc (EKSO) is not a strong buy for a beginner investor with a long-term strategy at this time. The lack of positive financial performance, no clear trading signals, and absence of significant catalysts make it prudent to hold off on investing in EKSO for now.
The MACD is positive and expanding, indicating a bullish trend. RSI is neutral at 63.256, suggesting no overbought or oversold conditions. Moving averages are converging, showing no strong directional momentum. The price is near resistance levels (R1: 10.312, R2: 10.942), which may limit further upside in the short term.
The stock has a 60% chance to increase by 5.71% in the next day and 16.72% in the next week, based on candlestick pattern analysis. The MACD is also showing a bullish signal.
No recent news or event-driven catalysts. Financial performance is weak, with revenue dropping by 38.31% YoY and EPS declining by 29.47% YoY. Gross margin also slightly decreased. Hedge funds, insiders, and congress trading data show no significant activity.
In Q4 2025, revenue dropped significantly by 38.31% YoY to $3.14M. Net income improved slightly but remains negative at -$4.67M. EPS declined by 29.47% YoY to -1.46, and gross margin slightly decreased to 53.22%. Overall, the company's financials show weak growth trends.
No analyst ratings or price target changes are available for EKSO at this time.
